Aaron McKinley is a writer, blogger and video game enthusiast with over five years of experience in web content and many more in playing games until the wee hours of the morning. His work spans many ...

A spoiler-filled discussion of episode 6 of the Apple TV sci-fi series. A spoiler-filled discussion of episode 6 of the Apple TV sci-fi series. is an entertainment editor covering streaming, virtual ...

Sagris D, Georgiopoulos G, Pateras K, et al. Atrial high-rate episode duration thresholds and thromboembolic risk: a systematic review and meta-analysis. J Am Heart Assoc 2021;10:[ePub ahead of print] ...

Operation D-6 was slated to be a sinister twin-layered attack, sources said. They added that the accused wanted to execute blasts in different cities on the anniversary of the Babri masjid demolition ...

6 Blasts In Delhi-NCR On December 6: 'Doctor Module' Had Babri Revenge Plan For years, Jaish-e-Mohammed has issued threats and called for revenge for the demolition of Babri Masjid, officials have ...

The Steam Machine has been revealed, a new plug-and-play PC with SteamOS that's the latest push from Valve into the hardware space. It's also, Valve hopes, a game-changer when it comes to bringing ...

ReNew already has an operating portfolio of 717 MW of operational wind capacity and 60 MW of solar capacity spread over 10 sites in Andhra Pradesh. India’s solar photovoltaic (PV) module manufacturing ...

Hurricane Melissa caused catastrophic damage in Jamaica, Haiti, Cuba, the Bahamas, and Dominican Republic. It was a high-end Category 5 hurricane, and one of the strongest hurricanes to make landfall ...

EMERYVILLE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with ...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced results from the Phase III HARMONi-6 trial, conducted in China and sponsored by our ...

HONG KONG, Oct. 16, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been ...